iSpecimen Inc.

NasdaqCM ISPC

iSpecimen Inc. Price to Book Ratio (P/B) on January 14, 2025: 0.37

iSpecimen Inc. Price to Book Ratio (P/B) is 0.37 on January 14, 2025, a -19.78% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.
  • iSpecimen Inc. 52-week high Price to Book Ratio (P/B) is 0.89 on October 21, 2024, which is 138.64% above the current Price to Book Ratio (P/B).
  • iSpecimen Inc. 52-week low Price to Book Ratio (P/B) is 0.21 on March 28, 2024, which is -42.16% below the current Price to Book Ratio (P/B).
  • iSpecimen Inc. average Price to Book Ratio (P/B) for the last 52 weeks is 0.50.
Key data
Date Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield Price to Earnings Ratio (P/E)
Market news
Loading...
NasdaqCM: ISPC

iSpecimen Inc.

CEO Ms. Leslie Hoyt
IPO Date June 17, 2021
Location United States
Headquarters 450 Bedford Street
Employees 53
Sector Health Care
Industries
Description

iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.

Similar companies

XGN

Exagen Inc.

USD 3.00

-3.85%

PSNL

Personalis, Inc.

USD 5.13

-4.11%

FONR

FONAR Corporation

USD 15.16

0.20%

CSTL

Castle Biosciences, Inc.

USD 25.46

-2.64%

OCX

OncoCyte Corporation

USD 2.15

3.36%

INBS

Intelligent Bio Solutions Inc.

USD 1.30

-1.52%

StockViz Staff

January 15, 2025

Any question? Send us an email